NOV 8 - 9 2017 Opens: 3:00 PM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
5th annual 24 Hours of Stem Cells™ virtual event
4 8 1589

Register for free to attend the 5th annual Gibco™ 24 Hours of Stem Cells™ virtual event, a major stem cell research event taking place around the world on November 9, 2017*.

During 24 Hours of Stem Cells, you can:

  • Access leading scientific presentations from prominent researchers and thought leaders around the world
  • Sharpen your stem cell skills and expertise with virtual training and certifications
  • Expand your research network and enrich your perspective on a global context

Experience all of this virtually, from the comfort of anywhere. Register today.


What attendees liked about last year's event Explore the virtual event




*Event hours: Log in any time after 8:00AM November 9th regardless of your time zone.

If you have additional questions, please contact Chelsie Fritz at


Show Resources
Click below each speaker's photo to watch their Webcast

  • Andrea Barbuti

  • Jun-An Chen
    Institute of Molecular Biology
      The focus of research in my laboratory is to elucidate how neurons establish individual identity in the developing nervous system and why only specific neuron subtypes are vulnerable in the neurodegenerative diseases. We tackle these questions via studying non-coding RNAs and their roles during motor neuron generation and degeneration. My lab employs motor neurons generated from mouse and human embryonic (ES) and induced pluripotent (iPS) stem cells, as well as mouse animal models to investigate motor neuron development and disease. We have developed and generated a series of stem cells and animal models to study functions of microRNA and lncRNA by "gain-of-function" and "loss-od-function" approaches. Besides elucidating the basic molecular mechanisms underlying specification of neuronal diversity during CNS development, I apply the stem cell system to study motor neuron diseases. In particular, I am engaged in the establishment and study of patient specific iPS cell based models of Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS). iPS cell derived motor neurons are used in my lab to perform deep sequencing from healthy and ALS motor neurons and to functionally characterize non-coding RNA pathology in motor neuron. I am also a core member of Neuroscience Program and RNA program in Academia Sinica, which provides strong and solid consortium to give advices and exchange the ideas for our projects. In summary, I have multidisciplinary approaches, from in vitro stem cells to in vivo mouse models, to study motor neuron development and degeneration.
    • Helmuth Gehart
      Postdoctoral researcher, Hubrecht Institute
        Helmuth Gehart received his PhD from ETH Zurich (Zurich, Switzerland) in 2013. During his PhD training with Prof. Romeo Ricci, Helmuth studied the mechanisms behind Type II Diabetes and the complex cellular checkpoints that maintain balance to prevent disease. Thereafter, Helmuth aimed to combine his knowledge of signaling and metabolism with the fascinating field of stem cell biology. Thus, he joined the group of Prof. Hans Clevers at the Hubrecht Institute (Utrecht, Netherlands). There he investigates adult tissue stem cells of the liver and their use in clinical research and regenerative medicine.
      • Alessandra Girogetti
        Center of Regenerative Medicine (CMRB)
          Dr. Giorgetti holds a Bachelor of Biology (1998) and PhD in Molecular Medicine from the University of Milan, Italy. She has a long-standing interest in hematopoietic stem cells, which started in her PhD thesis. She continued her studies in Dr. Rafii´s Lab at the Weill Cornell Medical College in New York. In 2008 she joined Center of Regenerative Medicine of Barcelona (CMRB). Her work contributed to the molecular understanding of nuclear reprogramming (Cell Stem Cell 2009; Nature Protocols 2010; Nature 2011, Stem Cells 2011, PNAS 2012, Nature Commun 2013). In 2012, she joined Inbiomed as Head of the Laboratory of Hematopoiesis and Blood Disorders. In 2013, she relocated to the Josep Carreras Leukaemia Research Institute where she contributed to develop new strategies for the in vitro generation of blood cells (Stem Cell Reports 2016; Exp Hematol 2017; Stem Cells 2017). Recently she relocated to the CMR[B] where she has just established herself as Team Leader.
        • Donna Goodenow
          Graduate Student, University of North Carolina at Charlotte
            I was born, raised and am currently living in Charlotte, North Carolina. I received my Bachelors of Science in Biology from Queens University of Charlotte. Now I am a third year Biology PhD student at the University of North Carolina at Charlotte (UNCC). Before beginning graduate school, I worked at Carolinas Medical Center in the General Surgery Research Department studying hemorrhagic shock and reperfusion injury in a rat model. At UNCC, I study the effects of dietary bioflavonoids on mouse embryonic stem cells to determine if these flavonoids cause improper DNA repair leading to chromosomal translocations and cancer.
          • Karl Koehler
            Assistant Professor, Indiana University School of Medicine
              Karl Koehler, PhD is an Assistant Professor of Otolaryngology-Head and Neck Surgery at Indiana University School of Medicine. He joined the faculty after completing his PhD degree in Medical Neuroscience in 2014 under the mentorship of Dr. Eri Hashino. Dr. Koehler began his career studying how embryonic and induced pluripotent stem cells could be used to produce neurons to treat hearing loss patients. His early work, published in Nature and Nature Protocols, detailed a novel culture system for growing mini inner ear organs, known as inner ear organoids, from mouse pluripotent stem cells. He then spearheaded an effort to decode the signaling mechanisms required to coax human pluripotent stem cells to become inner ear organoids. This work was recently published in Nature Biotechnology in June 2017. His research now focuses on using the organoid culture system as a platform to develop regenerative therapies for the inner ear and various craniofacial tissues. His work is funded by grants from the National Institute of Health and the Indiana Clinical and Translational Research Institute.
            • Alan Lam
              Associate Staff Scientist, Chinese University of Hong Kong
                Dr Alan Lam graduated with a PhD (Biochemistry) from Chinese University of Hong Kong. He is currently the associate staff scientist in the Stem Cell Bioprocessing Group at the Bioprocessing Technology Institute, A*STAR, Singapore. His research interest focuses on developing scalable platforms using microcarriers for adult and pluripotent stem cell derivation, expansion and differentiation. A list of his publications can be found at
              • Andrew Laslett
                Associate Professor, CSIRO Australian Regenerative Medicine Institute, Monash University
                  Dr. Andrew Laslett is a Research Team Leader with the CSIRO Manufacturing business unit, where he leads a human pluripotent stem cell biology research team; He also holds an Adjunct Associate Professor position with the Australian Regenerative Medicine Institute at Monash University and is an Honorary Senior Fellow with the School of BioSciences at Melbourne University. Since 2001, Andrew and his laboratory have focused on elucidating the complex biology of human embryonic stem cells (hESC), examined methods for the differentiation of hESC to renal progenitor cells and more recently begun comparing hESC to reprogrammed human cells termed induced pluripotent stem (iPS) cells. His laboratory is currently focused on exploiting the basic biology of these cell types to create novel cell lines and tools that enhance human pluripotent cell research translation within CSIRO, Australia and internationally. Prior to his current role with CSIRO, Andrew was a Senior Scientist and Group Leader of the Human Embryonic Stem Cell Technology Laboratory at the Australian Stem Cell Centre (ASCC) following Senior Research Fellow appointments in the Laboratory of Embryonic Stem Cell Biology and the Centre for Reproduction and Development, Monash Institute of Medical Research, Monash University. He obtained his BSc (Hons) and PhD (1996) from Monash University prior to undertaking postdoctoral positions in both Hong Kong and Philadelphia, USA.
                • Juliane Lopes De Assis
                  Universidade Estadual do Rio de Janeiro
                • Alessandro Magli
                  Assistant Professor, Univeristy of Minnesota
                    Dr. Alessandro Magli has worked in the skeletal muscle field for over 10 years. After completing his college studies at the University of Modena and Reggio Emilia (Italy), Dr. Magli earned his doctoral degree in the same institution by studying the molecular regulation of skeletal muscle differentiation. He later moved to the University of Minnesota where he conducted his post-doctoral training in the laboratory of Rita Perlingeiro. During this time, he investigated the mechanisms of cell fate choice during development, with a special focus on the mesodermal lineage derivatives. In particular, these studies recently resulted in the identification of markers for the purification of myogenic progenitors from differentiating human pluripotent stem cells, a finding that may enable the application of these ES-derived myogenic cells in cell therapy of muscle diseases. Dr. Magli is author of multiple scientific papers and, among other achievements, he was recipient of the Minnesota Regenerative Medicine educational award in 2015
                  • Cécile Martinat
                    INSERM director, iSTEM and President, French Stem Cell Society
                  • Kevin McCormack
                    Communications Director, California Institute for Regenerative Medicine
                      Kevin McCormack is the Communications Director at CIRM, the state's stem cell agency. He considers himself to be the official translator for the agency, working to turn complex language about equally complex science into everyday English that anyone can understand. Before joining the agency he spent more than 20 years working as a journalist, most of that in TV news in San Francisco.
                    • Alexander Meissner
                      Director, Max Planck Institute for Molecular Genetics
                        Alexander Meissner studied Medical Biotechnology at the Technical University Berlin before starting his PhD studies with Rudolf Jaenisch at the Whitehead Institute/MIT in 2002. He completed his PhD in 2006 and spent the next year and a half working with Rudolf Jaenisch and Eric Lander before starting his own lab as an assistant professor in the Department of Stem Cell and Regenerative Biology at Harvard University and as an associate member of the Broad Institute in 2008. He was promoted to associate professor in 2012 and full professor with tenure in 2015. In 2016 he has been appointed as Director and Head of the Department of Genome regulation at the Max Planck Institute for Molecular Genetics in secondary employment and changed it to his principal employment in 2017.
                      • Christine Mummery
                        Chair of Anatomy and Embryology and Professor of Developmental Biology, Leiden University Medical Center
                          Christine Mummery is Chair of Anatomy and Embryology and Professor of Developmental Biology at Leiden University Medical Center. Her research concerns cardiovascular development and disease models based on human pluripotent stem cells. Immediate interests are on developing biophysical techniques for characterization and functional analysis of cardiovascular cells from hPSC. In 2015 she became guest professor at the Technical University of Twente to develop organ-on-chip models. Dr. Mummery is a member of the Royal Netherlands Academy of Science, on the board of the Netherlands Medical Research Council and holds a European Research Council Advanced Grant to study cardiac development and disease in humans based on stem cell models. She wrote a lay-guide on stem cells "Stem Cell: Scientific Facts and Fiction" (Elsevier 2014) and is Editor-in-Chief of Stem Cell Reports, the journal of the International Society of Stem Cell Research. She is also on the editorial boards of Cell Stem Cell, Cardiovascular Research and Stem Cells.
                        • Alessandro Prigione
                          Independent Team Leader, Max Delbrueck Center for Molecular Medicine (MDC)
                            Dr. Prigione is an Independent Team Leader at the Max Delbrueck Center for Molecular Medicine (MDC) in Berlin. His group was established in 2015 with the generous support of a junior investigator grant from the German Ministry of Education and Research (BMBF). Dr. Prigione received a M.D. from the University of Milan in 2002 and a Ph.D. from the San Raffaele Institute of Milan in 2008. During his Ph.D., Dr. Prigione worked on neurological diseases at the University of Milan-Bicocca and on mitochondrial disorders at the University of California in Davis, USA. As postdoctoral scientist at the Max Planck Institute for Molecular Genetics in Berlin, Dr. Prigione described for the first time the reconfiguration occurring to mitochondria during the reprogramming of human fibroblasts to iPSCs. The focus of the Prigione lab is now the application of iPSCs in modeling and treatment discovery of neurological diseases with mitochondrial impairment. His latest work was published in Cell Stem Cell in January 2017 and demonstrated the use of iPSC-derived neural cells for drug discovery of neurological disorders caused by mitochondrial DNA mutations.
                          • Stevens Rehen
                            Head of Research, D'Or Institute for Research and Education and Professor of Biomedical Sciences, Federal University of Rio de Janeiro
                              Stevens Rehen received his Bachelor's degree, Master's degree, and Ph.D. at the Federal University of Rio de Janerio in Brazil. He later completed postdoctoral training at the University of California San Diego and The Scripps Research Institute. Over the past five years, Stevens has published over 76 peer-reviewed publications. Currently, Stevens is a Full Professor at the Federal University of Rio de Janerio. Additionally, he is the Head of Research at D'Or Institute for Research and Education (IDOR) and Regional Committee Member of the Pew Latin American Program in the Biomedical Sciences.
                            • Meritxell Rovira
                                Meritxell Rovira holds a Bachelor in Biology (2001) from University of Barcelona and a PhD in Health and Life Science (2007) from University Pompeu Fabra. After her PhD she moved to USA in 2008 for her postdoctoral training at Johns Hopkins/School of Medicine to work in Steve D Leach and Mike Parsons laboratories, where she acquired expertise in adult pancreatic progenitors in mouse and zebrafish models. She came back to Barcelona in 2011 as a Marie Curie postdoctoral fellow at Jorge Ferrer laboratory (IDIBAPS) where she gained expertise in the field of epigenetics. After her postdoctoral training, she joined Núria López-Bigas laboratory at IRB as a research associate to stablish and supervise the experimental part of Núria's lab. She joined the CMR[B] in 2017 after being awarded with a Jovenes Investigadores fellowship from the Spanish Ministry. Meritxell's main research interest is the study of pancreatic progenitors in zebrafish, mouse and human. Embryonic pancreatic multipotent progenitors and adult pancreatic duct cells express common markers in all animal species studied thus far; suggesting that adult duct cells might be exploited to create a pool of β-cell progenitors. Thus my main research interest is to understand the transcriptional and epigenetic changes that occur between embryonic progenitors and adult cells, as well as the influence of the extrinsic signals from the surrounding mesenchymal cells. This knowledge will allow the identification of the molecular mechanisms that restrict the lineage potential of duct cells and could be used to create a model of β-cell regeneration for the treatment of Type 1 Diabetes.
                              • Jens Schwamborn
                                Chief Scientific Officer (CSO), Braingineering Technologies SARL
                                  Since 2013 Jens C. Schwamborn, PhD, is head of the Developmental and Cellular Biology group at the Luxembourg Centre for Systems Biomedicine (LCSB) as well as Professor at the University of Luxembourg. Additionally, since 2016 Jens is Chief Scientific Officer of the biotech company Braingineering Technologies. In 2002 Jens obtained is diploma in Biochemistry from the University Witten/Herdecke in Germany and in 2005 his PhD in Biology from the University Muenster in Germany. He worked as a postdoctoral researcher at the Institute for Molecular Biotechnology in Vienna / Austria. The focus of his work over the last years was on Neurobiology, Stem Cell research and Parkinson's disease. In particular he is interested in using human induced pluripotent stem cells for the development of advanced approaches for in vitro disease modeling. Jens published more than 50 papers in peer reviewed journals, holds several patents and severs as reviewer for numerous journals and funding agencies.
                                • Rebecca Shumbata
                                  Special Sales Account Manager, Mary Ann Liebert, Inc.
                                    Rebecca Appleby Shumbata received her degree from Connecticut College. Today, Rebecca is a scholarly publishing professional with over 15 years of experience. At Mary Ann Liebert publishers, Rebecca works with organizations to find topics and customize existing content, create new content, or extend planned live content into enduring educational materials that improve branding and generate leads. Before joining Mary Ann Liebert publishers, Rebecca worked with publishers and institutions to improve the dissemination of research at Kudos. Prior to that, Rebecca served as Senior Global Sales Manager for Hosting Platforms at Ingenta, previously Publishing Technology. Rebecca has 8 additional years of publishing experiencing working for publishers, Cell Press, published by Elsevier, and the New England Journal of Medicine, published by the Massachusetts Medical Society. Rebecca is also co-Chair of the Society for Scholarly Publishing Development Committee.
                                  • Nina Tandon
                                    CEO and co-founder, EpiBone
                                      Nina Tandon is CEO and co-founder of EpiBone, the world's first company growing living human bones for skeletal reconstruction. She is the co-author of Super Cells: Building with Biology, a book that explores the new frontier of biotech. She is a TED Senior Fellow, Adjunct Professor of Electrical Engineering at the Cooper Union and a former Staff Associate Postdoctoral Researcher in the Laboratory for Stem Cells and Tissue Engineering, Columbia University. She has a Bachelor's in Electrical Engineering from the Cooper Union, a Master's in Bioelectrical Engineering from MIT, a PhD in Biomedical Engineering, and an MBA from Columbia University. Her PhD research focused on studying electrical signaling in the context of tissue engineering, and has worked with cardiac, skin, bone, and neural tissue.
                                    • Adrian Teo
                                      Independent Fellow, IMCB, A*STAR and Adjunct Assistant Professor, SBS and LKCMedicine, NTU and Adjunct Assistant Professor, NUS Medicine, NUS
                                        Adrian Teo is an Independent Fellow at IMCB and an Adjunct Assistant Professor at NTU and NUS. He obtained his B.Sc. (1st Class) from NUS and then worked on human pluripotent stem cells (hPSCs) with Ray Dunn, Ph.D., and Alan Colman, Ph.D., at ES Cell International Pte. Ltd. followed by IMB. In April 2008, he joined the laboratory of Ludovic Vallier, Ph.D., at the University of Cambridge to pursue his Ph.D., under the AGS(O) scholarship. Concurrently, he was also an Honorary Cambridge Commonwealth Trust Scholar. He completed his Ph.D. in July 2010 and joined the laboratory of Ray Dunn, Ph.D., at IMB as a postdoctoral fellow before heading to the laboratory of Rohit Kulkarni, M.D. Ph.D., at Joslin Diabetes Center, Harvard Medical School. During his fellowship, he obtained HSCI seed grants and a JDRF fellowship to pursue his research interests in using hPSCs for in vitro disease modelling of diabetes. He currently runs the Stem Cells and Diabetes Laboratory with a major focus on differentiating human pluripotent stem cells (hPSCs) into pancreatic cells and cell types affected in diabetic complications to dissect the pathology of diabetes and its complications
                                      Live Chats

                                      Scheduled Live Chats
                                      Chat live with our stem cell experts on the topic of your interest – shown below. Specific times will be available shortly.

                                      LIVE CHAT: PSC culture
                                      Rhonda Newman and Lauren Sangenario
                                      Many different PSC culture media are available and range from feeder-dependent to feeder-free, and from many animal-derived components to more xeno-free formulations. Our experts have tried them all. Learn how they compare and recommend different media for your applications.

                                      LIVE CHAT: Reprogramming
                                      Uma Lakshmipathy and Chad MacArthur
                                      Find out how our experts have evaluated different reprogramming methodologies and which ones they recommend for your cell type.

                                      LIVE CHAT: Stem cell characterization and analysis
                                      Don Paul Kovarcik and Uma Lakshmipathy
                                      Characterizing and analyzing cells may be one of the most important steps in stem cell culture. Talk about your techniques and hear our expert opinions about different approaches to creating a complete characterization profile for your cells.

                                      LIVE CHAT: Transfection
                                      James Kehler and Donna Trollinger
                                      Ask our experts about the latest in our transfection portfolio including superior transfection efficiency in the most difficult stem cell assays.

                                      LIVE CHAT: Gene editing
                                      Erik Willems and Jason Carte
                                      Ask our experts about which gene editing tools work best for different cell lines and how to improve editing outcomes, or engage in a discussion about how gene editing in stem cells may change the future of modern medicine.

                                      LIVE CHAT: Neural cell culture systems
                                      David Kuninger and Navjot Kaur
                                      Discuss the challenges associated with neural cell culture systems and how our latest product improvements and solutions can help.

                                      LIVE CHAT: Clinical research
                                      Eric Roos, Sandy Kuligowski and Kasey Kime
                                      In need of practical advice on designing a cell-based clinical trial logistics strategy? Ask our knowledgeable scientists about the essential elements of material handling to control costs and ensure success.

                                      LIVE CHAT: Mouse research
                                      Soo Shin, Mark Kennedy, and Joanna Asprer


                                      Learn about the various educational opportunities available at this year’s virtual event.

                                      NEW – Career development center

                                      This year 24 Hours of Stem Cells is introducing a career development track that will allow you to access:

                                      • Free career advice from prominent researchers in the field
                                      • Career development resources such as resume building and career planning
                                      • Educational opportunities such as virtual training and handbooks

                                      Take advantage of these new career development opportunities by visiting the Career Development Center.

                                      Event certification
                                      Participate in the following activities within the virtual environment to earn an event certificate of completion and free T-shirt*.  Event certification is only available until February 9, 2018.

                                      • View two presentations of your choice
                                      • Submit a question to one of our experts via a scheduled chat, a presentation, or a booth
                                      • Visit a booth in the Exhibit Hall
                                      • Visit a virtual training lab
                                      • Complete a short survey

                                      Virtual training
                                      Test your knowledge and sharpen your stem cell skills in one of our virtual training labs. Topics include pluripotent stem cell culture, basic cell culture, transfection and protein expression.


                                      *No purchase necessary. This promotion is available only to qualifying attendees of 24 Hours of Stem Cells who earned an event certification. Qualifying attendees will receive a T-shirt. Qualifying attendees in China will receive a LED table lamp. Free T-shirt or lamp is available to eligible participants who submit a request no later than February 9, 2018 or until gift supplies are depleted, whichever comes first. The estimated value of the T-shirt is $12.00 USD, and the estimated value of the lamp is $15.00 USD. One free gift per person. Life Technologies will fulfill T-shirt size requests whenever possible, but reserves the right to substitute sizes if necessary. Healthcare professionals may not participate in this promotion. Government Officials may not participate in this promotion. The term Government Official includes anyone who acts in an official capacity for or on behalf of a government entity, department, or agency. By registering, you warrant that you are not prohibited by employment, contract, or law from accepting a gift from Life Technologies. Offer void where prohibited, licensed, or restricted by federal, state, provincial, or local laws or regulation or agency/institutional policy. Other restrictions may apply.


                                      General LabRoots Questions

                                      For bugs, spam, technical support or questions please call +1-714-463-4673 or email  
                                      Contact us

                                      Virtual Events and Webinars

                                      Supported Configurations

                                      • Operating System Internet Explorer Firefox Chrome Safari
                                        Vista IE8+ FF10+ Chrome15+
                                        Windows 7 IE8+ FF10+ Chrome15+
                                        Windows 8 IE10 FF10+ Chrome15+
                                        Mac OS X   FF10+ Chrome15+ Safari5.1+
                                      • Cookie settings: session cookies enabled
                                      • Browser configuration must have JavaScript enabled
                                      • Adobe Flash player 10.2 or later

                                      To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                      Internet Connection

                                      • A minimum of 100Kbps is recommended for audio-only events
                                      • A minimum of 300Kbps is recommended for speaker on-video events

                                      Computer Equipment

                                      • Screen Resolution: Minimum 1024x768
                                      • Video Card: 65,000 colors minimum
                                      • Sound card and speakers (or headphones) for hearing webcast in full format
                                      • Audio Card: 16-bit minimum
                                      • RAM: 512MB of free RAM

                                      Firewall Protocol

                                      • HTTP on port 80 or HTTPS on port 443
                                      • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                      • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                      Work-At-Home Attendees

                                      • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                      For A Seamless Experience

                                      When using a mobile device, FREE Mobile Apps are available:

                                      - For viewing Webinars:

                                      - For viewing Virtual Events

                                      Attendee Guide

                                      • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                      Virtual Event and Webinar Support:

                                      Continuing Education (CME/CE) Support

                                      Loading Comments...
                                      Show Resources
                                      Event Countdown
                                      • 0 Days
                                      • 0 Hours
                                      • 0 Minutes
                                      • 0 Seconds